Predictions of Systemic, Intracellular, and Lung Concentrations of Azithromycin With Different Dosing Regimens Used in COVID‐19 Clinical Trials

Azithromycin (AZ), a broad‐spectrum macrolide antibiotic, is being investigated in patients with coronavirus disease 2019 (COVID‐19). A population pharmacokinetic model was implemented to predict lung, intracellular poly/mononuclear cell (peripheral blood monocyte (PBM)/polymorphonuclear leukocyte (...

Descripción completa

Detalles Bibliográficos
Autores principales: Hughes, Jim H., Sweeney, Kevin, Ahadieh, Sima, Ouellet, Daniele
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2020
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7300789/
https://www.ncbi.nlm.nih.gov/pubmed/32511867
http://dx.doi.org/10.1002/psp4.12537

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7300789/
https://www.ncbi.nlm.nih.gov/pubmed/32511867
http://dx.doi.org/10.1002/psp4.12537

Ejemplares similares